Executive Director Head Of Safety Innovation
CurrentSafety Innovation includes Cardiovascular Safety, Hepatic Safety, Microphysiological Systems, Genetic Toxicology, RNA Safety, Protacs Safety, and Immuno toxicology.
Please complete the CAPTCHA to continue
@astrazeneca.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Ann Doherty is listed as Executive Director Head of Safety Innovation at AstraZeneca at AstraZeneca, a with 59317 employees, based in Milton, England, United Kingdom. AeroLeads shows a work email signal at astrazeneca.com and a matched LinkedIn profile for Ann Doherty.
Ann Doherty previously worked as Executive Director Head of Safety Innovation at Astrazeneca and Global Head Functional and Mechanistic Safety at Astrazeneca. Ann Doherty holds Phd, Genetic Toxicology from University Of Wales, Swansea.
This section adds company-level context without repeating Ann Doherty's masked contact details.
AeroLeads found 1 current-domain work email signal for Ann Doherty. Compare company email patterns before reaching out.
Ann Doherty is a Executive Director Head of Safety Innovation at AstraZeneca at AstraZeneca. She possess expertise in toxicology, drug development, in vitro, in vivo, glp and 20 more skills.
Listed skills include Toxicology, Drug Development, In Vitro, In Vivo, and 21 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Cambridge, England, United Kingdom
Safety Innovation includes Cardiovascular Safety, Hepatic Safety, Microphysiological Systems, Genetic Toxicology, RNA Safety, Protacs Safety, and Immuno toxicology.
Functional and Mechanistic Safety includes Genetic Toxicology, Safety & Mechanistic Pharmacology, Cardiovascular Safety Immuno-toxicology team, Gene editing team and Hepatic Safety Teams.
Other employees you can reach at astrazeneca.com. View company contacts for 59317 employees →
Caio Veloso
Colleague at AstrazenecaSão Paulo, Brazil
View →
SD
Surajit Das
Colleague at AstrazenecaKolkata, West Bengal, India
View →
PD
Patrick De Kraaij
Colleague at AstrazenecaAmsterdam, North Holland, Netherlands
View →
VS
Vikash Sharma
Colleague at AstrazenecaSan Mateo, California, United States
View →
BK
Babu Kumar S D
Colleague at AstrazenecaChennai, Tamil Nadu, India
View →
LG
Liza Goh
Colleague at AstrazenecaPetaling Jaya, Selangor, Malaysia
View →
VD
Valérie Dekerle
Colleague at AstrazenecaSt.-Quentin, Hauts-De-France, France
View →
PS
Przemysław Szewczyk
Colleague at AstrazenecaWarsaw, Mazowieckie, Poland
View →
MA
Megha Anand
Colleague at AstrazenecaMacclesfield, England, United Kingdom
View →
JB
Jonas Bergström
Colleague at AstrazenecaGreater Stockholm Metropolitan Area, Sweden
View →
Quick answers generated from the profile data available on this page.
Ann Doherty works for AstraZeneca.
Ann Doherty is listed as Executive Director Head of Safety Innovation at AstraZeneca at AstraZeneca.
AeroLeads has found 1 work email signal at @astrazeneca.com for Ann Doherty at AstraZeneca.
Ann Doherty is based in Milton, England, United Kingdom while working with AstraZeneca.
Ann Doherty has worked for Astrazeneca and University Of Bristol.
Ann Doherty's colleagues at AstraZeneca include Caio Veloso, Surajit Das, Patrick De Kraaij, Vikash Sharma, and Babu Kumar S D.
You can use AeroLeads to view verified contact signals for Ann Doherty at AstraZeneca, including work email, phone, and LinkedIn data when available.
Ann Doherty holds Phd, Genetic Toxicology from University Of Wales, Swansea.
Ann Doherty is listed with skills including Toxicology, Drug Development, In Vitro, In Vivo, Glp, Cytogenetics, Assay Development, and Cell Culture.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Ann Doherty you were looking for.